Charles Nakar, M.D.

Charles Nakar, M.D., serves as an IHTC Pediatric Hematologist. Dr. Nakar attended medical school at Ben-Gurion University in Israel. Dr. Nakar completed his Pediatric Residency at Ben-Gurion University and the North Shore-Long Island Jewish System/Schneider Children’s Hospital Program. Dr. Nakar completed his Pediatric Hematology/Oncology fellowship at Cornell University and Memorial Sloan Kettering Cancer Center in New York. Dr. Nakar has a special interest in hemophilia, specifically surgical interventions, management and outcomes, inhibitor development and eradication, and intracranial hemorrhage (ICH). Dr. Nakar also has expertise in platelet pathophysiology, genetic disorders, and ITP. In 2010 Dr. Nakar published a paper in Haemophilia analyzing the safety and efficacy of recombinant activated factor VII in the treatment of ICH in hemophilia patients with inhibitors. Dr. Nakar works within the IHTC to improve service delivery to bleeding disorder patients, including improved pre-natal counseling and care to newborns and infants.